Russell Investments Group
CRMD icon

Russell Investments Group’s CorMedix CRMD Stock Holding History

Russell Investments Group’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$312K Buy
39,792
+29,329
+280% +$232K ﹤0.01% 3003
2026
Q1 		$71K Sell
10,463
-2,932
-22% -$21.7K ﹤0.01% 3196
2025
Q4 		$156K Buy
13,395
+1,355
+11% +$15K ﹤0.01% 2921
2025
Q3 		$140K Buy
12,040
+5,487
+84% +$66.3K ﹤0.01% 2930
2025
Q2 		$80.7K Buy
6,553
+1,190
+22% +$13.1K ﹤0.01% 2876
2025
Q1 		$33K Buy
5,363
+921
+21% +$9.53K ﹤0.01% 2999
2024
Q4 		$36K Sell
4,442
-45
-1% -$449 ﹤0.01% 2895
2024
Q3 		$36.3K Buy
4,487
+3,475
+343% +$18.8K ﹤0.01% 2844
2024
Q2 		$4.38K Buy
+1,012
New +$5.14K ﹤0.01% 3242
2024
Q1 		– Sell
-82
Closed -$308 – 3318
2023
Q4 		$308 Sell
82
-44
-35% -$151 ﹤0.01% 3153
2023
Q3 		$466 Buy
+126
New +$501 ﹤0.01% 3411

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Russell Investments Group's CRMD Position: Q2 2026 in Review

Russell Investments Group increased its CorMedix (CRMD) stake by 280% in Q2 2026, buying an estimated $232K and bringing the position to 39,792 shares worth $312K. The position accounts for ﹤0.01% of the portfolio, ranked #3003.

Russell Investments Group first reported a position in CRMD in Q3 2023 and has held it in 11 quarters since. 193 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • Russell Investments Group held 39,792 shares of CorMedix worth $312K as of Q2 2026.
  • Russell Investments Group bought 29,329 CorMedix shares in Q2 2026, an estimated $232K.
  • CorMedix made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #3003 holding.
  • Russell Investments Group first reported a position in CorMedix in Q3 2023 and has held it in 11 quarters since.
  • 193 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.